{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:30:31Z","timestamp":1754109031969,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802767, 81860117"],"award-info":[{"award-number":["81802767, 81860117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Liver cancer is now the fourth most common cancer in China. The most important factor in decreasing the overall survival is recurrence. Nearly 40%\u201370% of patients would be detected with intrahepatic or extrahepatic recurrence in 5 years after R0 resection. The intestine is not a usual site for extrahepatic metastasis. Only one case of hepatocellular carcinoma (HCC) metastasis to the appendix has been reported so far. So, it poses a difficulty for us to develop treatment plan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>Here, we report a very rare case of a recurrent HCC patient. R0 resection was first performed on this 52-year-old men who was diagnosed with Barcelona Clinic Liver Cancer stage A HCC. Different from other cases, a solitary metastasis to the appendix was detected 5 years after the R0 resection. After discussing with the multidisciplinary team, we decided to perform surgical resection again. The final postoperative pathology confirmed HCC. Complete responses were detected in this patient after the combined treatment of transarterial chemoembolization, angiogenesis inhibitors, and immune checkpoint inhibitors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Because solitary metastasis to the appendix in HCC is very rare, this case might be the first reported in HCC patients after R0 resection. This case report highlights the efficacy of the combination of surgery, local regional therapy, angiogenesis inhibitors, and immune treatment in HCC patients with solitary metastasis to the appendix.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2023.1081326","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T05:05:21Z","timestamp":1680152721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Solitary metastasis to the appendix after curative treatment of HCC"],"prefix":"10.3389","volume":"10","author":[{"given":"Zun-Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.21037\/hbsn-20-480","article-title":"2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights","volume":"9","author":"Xie","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"B3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis","volume":"261","author":"Tabrizian","year":"2015","journal-title":"Ann Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/hepr.13612","article-title":"Report of the 21st nationwide follow-up survey of primary liver cancer in Japan (2010\u20132011)","volume":"51","author":"Kudo","year":"2021","journal-title":"Hepatol Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1259\/bjr\/79390979","article-title":"Metastasis to the appendix from a hepatocellular carcinoma manifesting as acute appendicitis: CT findings","volume":"81","author":"Kim","year":"2008","journal-title":"Br J Radiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000268405","article-title":"Malignant transformation of liver adenoma: an analysis of the literature","volume":"27","author":"Farges","year":"2010","journal-title":"Dig Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.21037\/hbsn.2018.08.01","article-title":"Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus","volume":"7","author":"Wen","year":"2018","journal-title":"Hepatobiliary Surg Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.11622\/smedj.2013262","article-title":"Hepatocellular carcinoma with colonic metastasis","volume":"55","author":"Ou","year":"2014","journal-title":"Singapore Med J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1148\/radiology.216.3.r00se24698","article-title":"Extrahepatic metastases of hepatocellular carcinoma","volume":"216","author":"Katyal","year":"2000","journal-title":"Radiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00004728-200201000-00014","article-title":"Radiologic findings of gastrointestinal tract involvement in hepatocellular carcinoma","volume":"26","author":"Park","year":"2002","journal-title":"J Comput Assist Tomogr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12957-020-01960-2","article-title":"Colon metastasis from hepatocellular carcinoma: a case report and literature review","volume":"18","author":"Yu","year":"2020","journal-title":"World J Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.12998\/wjcc.v7.i15.2044","article-title":"Left colonic metastasis from primary hepatocellular carcinoma: a case report","volume":"7","author":"Tagliabue","year":"2019","journal-title":"World J Clin Cases"},{"key":"B15","doi-asserted-by":"publisher","first-page":"814","DOI":"10.4103\/jcrt.JCRT_217_20","article-title":"Colonic metastasis from hepatocellular carcinoma after treated by ablation and transarterial chemoembolization manifested by intestinal obstruction: a case report and review of the literature","volume":"17","author":"Mu","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3350\/kjhep.2010.16.4.397","article-title":"Sigmoid colon metastasis from hepatocellular carcinoma","volume":"16","author":"Yoo","year":"2010","journal-title":"Korean J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.12998\/wjcc.v8.i16.3534","article-title":"Concurrent hepatocellular carcinoma metastasis to stomach, colon, and brain: a case report","volume":"8","author":"Kim","year":"2020","journal-title":"World J Clin Cases"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.3889\/oamjms.2019.837","article-title":"A rare colonic metastasis case from hepatocellular carcinoma","volume":"7","author":"Pham","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s40792-021-01349-7","article-title":"Colonic metastasis of hepatocellular carcinoma with repeated retroperitoneal bleeding: a case report","volume":"7","author":"Miyauchi","year":"2021","journal-title":"Surg Case Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3892\/etm.2016.3108","article-title":"Effect of immune suppression on metastasis in a patient with hepatocellular carcinoma metastasized to the colon and stomach: a case report","volume":"11","author":"Wu","year":"2016","journal-title":"Exp Ther Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40792-016-0241-7","article-title":"Surgical resection of recurrent extrahepatic hepatocellular carcinoma with tumor thrombus extending into the right atrium under cardiopulmonary bypass: a case report and review of the literature","volume":"2","author":"Ohta","year":"2016","journal-title":"Surg Case Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-17-2899","article-title":"Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study","volume":"24","author":"Wang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/vaccines9050532","article-title":"The evolving role of immune checkpoint inhibitors in hepatocellular carcinoma treatment","volume":"9","author":"Leone","year":"2021","journal-title":"Vaccines"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/hep.31921","article-title":"Lenvatinib targets FGF receptor 4 to enhance antitumor immune response of anti-programmed cell death-1 in HCC","volume":"74","author":"Yi","year":"2021","journal-title":"Hepatol Baltim Md"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2147\/JHC.S332420","article-title":"Lenvatinib combined with anti-PD-1 antibodies plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a multicenter retrospective study","volume":"8","author":"Wu","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"B27","doi-asserted-by":"publisher","first-page":"650394","DOI":"10.3389\/fonc.2021.650394","article-title":"Combination of sorafenib, camrelizumab, transcatheter arterial chemoembolization, and stereotactic body radiation therapy as a novel downstaging strategy in advanced hepatocellular carcinoma with portal vein tumor thrombus: a case series study","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"833884","DOI":"10.3389\/fonc.2022.833884","article-title":"Effectiveness of TKI inhibitors combined with PD-1 in patients with postoperative early recurrence of HCC: a real-world study","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-11-2175","article-title":"Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"B31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e005414","DOI":"10.1136\/jitc-2022-005414","article-title":"Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model","volume":"10","author":"Sov\u00e9","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2217\/fon-2019-0097","article-title":"RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma","volume":"15","author":"Qin","year":"2019","journal-title":"Future Oncol Lond Engl"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet Lond Engl"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2023.1081326\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T05:05:25Z","timestamp":1680152725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2023.1081326\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":34,"alternative-id":["10.3389\/fsurg.2023.1081326"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2023.1081326","relation":{},"ISSN":["2296-875X"],"issn-type":[{"type":"electronic","value":"2296-875X"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"article-number":"1081326"}}